Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Vanguard S&P 500 ETF
VOO
$971B
| $225M | 0.12% |
467,416
-11,419
| -2% | -$5.23M |
|
177
Cencora
COR
$62.2B
| $224M | 0.12% |
921,755
+117,888
| +15% | +$27.1M |
|
|
AVDL
178
DELISTED
Avadel Pharmaceuticals
AVDL
| $218M | 0.12% |
12,915,160
+1,789,830
| +16% | +$26.7M |
|
179
Prologis
PLD
$137B
| $217M | 0.12% |
1,664,336
-463,624
| -22% | -$60.6M |
|
180
Blackbaud
BLKB
$1.65B
| $211M | 0.11% |
2,840,576
+53,057
| +2% | +$4.05M |
|
181
Elevance Health
ELV
$83.7B
| $210M | 0.11% |
405,094
-14,138
| -3% | -$7.03M |
|
182
Ziff Davis
ZD
$1.95B
| $204M | 0.11% |
3,239,654
+10,303
| +0.3% | +$684K |
|
183
Walker & Dunlop
WD
$1.75B
| $202M | 0.11% |
1,998,145
-34,145
| -2% | -$3.28M |
|
184
Apollo Global Management
APO
$71.9B
| $199M | 0.11% |
1,772,486
-10,181
| -0.6% | -$1.07M |
|
185
Salesforce
CRM
$149B
| $195M | 0.11% |
648,753
+21,298
| +3% | +$6.15M |
|
186
APi Group
APG
$17B
| $192M | 0.1% |
7,327,068
+7,212,804
| +6,312% | +$168M |
|
187
Neurocrine Biosciences
NBIX
$18.4B
| $190M | 0.1% |
1,378,513
-172,854
| -11% | -$23.6M |
|
188
Xylem
XYL
$29.7B
| $188M | 0.1% |
1,456,290
-12,670
| -0.9% | -$1.53M |
|
189
Alight
ALIT
$523M
| $188M | 0.1% |
953,024
+16,565
| +2% | +$3M |
|
190
Sempra
SRE
$59.2B
| $188M | 0.1% |
2,610,647
-662,028
| -20% | -$47.4M |
|
191
Keysight
KEYS
$52.2B
| $185M | 0.1% |
1,180,836
-342,021
| -22% | -$52.6M |
|
192
Occidental Petroleum
OXY
$53.6B
| $184M | 0.1% |
2,838,767
-242,636
| -8% | -$14.5M |
|
193
Dollar Tree
DLTR
$24.4B
| $182M | 0.1% |
1,363,426
-6,357
| -0.5% | -$875K |
|
|
GTLS
194
DELISTED
Chart Industries
GTLS
| $181M | 0.1% |
1,099,953
+31,553
| +3% | +$4.24M |
|
195
Capital One
COF
$130B
| $181M | 0.1% |
1,216,724
+5,473
| +0.5% | +$741K |
|
196
Sotera Health
SHC
$5.06B
| $179M | 0.1% |
14,892,868
+4,525,056
| +44% | +$67.3M |
|
197
OSI Systems
OSIS
$3.64B
| $179M | 0.1% |
1,249,889
+19,683
| +2% | +$2.58M |
|
198
Ryan Specialty Holdings
RYAN
$5.96B
| $172M | 0.09% |
3,095,804
-8,112
| -0.3% | -$388K |
|
|
NVO
199
Novo Nordisk
NVO
$225B
| $169M | 0.09% |
1,317,710
-251,854
| -16% | -$30M |
|
200
IDEAYA Biosciences
IDYA
$3.48B
| $167M | 0.09% |
3,808,450
+256,559
| +7% | +$11M |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.